Healthcare
Ampersand Capital Partners invests in GeneWerk
Pharmaceuticals-focused GP aims to support GeneWerk's growth to meet demand for its services
Apax sells Neuraxpharm to Permira
Deal values the company at more than €1.6bn and is set to generate returns for Apax of 3.5x money
Morningside leads £40.6m series-B for Immune Regulation
Morningside's Isaac Cheng will join the company's board of directors
PAI buys stake in Amplitude from Apax
Sale ends a nine-year holding period for Apax, which bought the business from Weinberg and Initiative & Finance
Novo, Sanofi lead $83m round for Lava Therapeutics
Corporate venture firms were joined by new and existing investors, including Gilde Healthcare
Sagard NewGen backs Laboratoires Delbert
Socadif Capital Investissement, Idia Capital Investissement and MACSF also invest in the company
AMoon leads £23m series-A for Mina Therapeutics
Gur Roshwalb, a managing director for AMoon, has joined the board of directors at Mina
Nord Holding buys Oton, Ohrwerk, creates AudiOsono
GP plans to grow the hearing care buy-and-build platform to 150 sites in Germany via add-ons
Columbus Venture invests in €7.4m round for Algenex
Columbus deploys capital from Columbus Life Science Fund II, which targets early-stage biotech startups
GP Profile: ArchiMed
Following the close of its new €1bn fund, ArchiMed's Denis Ribon discusses the firm's fundraising experience and investment pipeline
Heal Capital leads series-A for CereGate
Existing investors High-Tech Gründerfonds (HTGF) and TruVenturo also take part in the round
Nord Holding acquires majority stake in HG Medical
Orthopaedic implants producer saw interest from a number of sponsors in a structured auction process
Mezzanine Management sells MBL to INVL
Seventh exit for Mezzanine Management's AMC funds in the last 12 months
Mandarin Capital buys Sidam
GP intends to create a platform for new acquisitions across the biomedical sector in Italy
Claris Biotech I holds €30m first closing
Fund targets early-stage rounds across the biopharmaceutical industry, focusing on oncology, immunology and rare diseases
Polaris acquires Swedish dental clinic chain Distrikstandvården
Deal is the result of a sale auction, for which ABG Sundal Collier had been mandated last year
Summit Partners invests in CluePoints
Company plans to use the fresh capital to boost its growth and expand its international presence
Nexxus Iberia backs Mercurius Health
GP invests via Nexxus Iberia Private Equity Fund I, which held a final close on €170m in February 2020
EQT Infrastructure in exclusivity to acquire IK's Colisée
During IK's three-year holding period, the company tripled in size, according to a statement
ArchiMed closes MED Platform I on €1bn
Oversubscribed fund closes above its €800m target after a couple of years on the road
Baring Vostok, Vostok New Ventures sell Doc+
Baring Vostok Private Equity and Yandex provided $5m of financing to Doc+ in 2017
Panakes to launch €120m second fund within months
VC expects to start raising capital by the end of the year and hold a first close in H1 2021
GP-backed SSI Diagnostica acquires CTK Biotech
Deal comes four years after the GP carved out SSI Diagnostica from the Danish government for DKK 250m
Ardian's Unither buys Chinese pharma company NRB
With this acquisition, Unither plans to accelerate the development of its business in China
